3.0
5 Apr 2014
Former employee, more than 3 years
Boston, MA
Recommend
CEO approval
Business outlook
Pros
Good benefits Good location Cambridge Great R&D Group Great Leadership at the top in MS Franchise
Cons
Culture is not as good as it was before acquisition Much more red tape to go through for approvals second MS drug did not get approved in the US, which has taken wind out of sails of MS Organization